Atlas Venture Life Science Advisors, LLC Top Holdings and 13F Report (2023) → Guard Against the Coming Financial Upheaval (From Porter & Company) (Ad) About Atlas Venture Life Science Advisors, LLCInvestment ActivityAtlas Venture Life Science Advisors, LLC has $1.08 billion in total holdings as of March 31, 2023.Atlas Venture Life Science Advisors, LLC owns shares of 16 different stocks, but just 6 companies or ETFs make up 80% of its holdings.Approximately 3.29% of the portfolio was purchased this quarter.About 11.16% of the portfolio was sold this quarter.This quarter, Atlas Venture Life Science Advisors, LLC has purchased 16 new stocks and bought additional shares in 0 stocks.Atlas Venture Life Science Advisors, LLC sold shares of 7 stocks and completely divested from 1 stock this quarter.Largest Holdings Dyne Therapeutics, Inc. $227,691,661Kymera Therapeutics $216,169,952Disc Medicine $142,403,127Day One Biopharmaceuticals $106,227,846TF Financial $102,970,189 Largest New Holdings this Quarter Q32 Bio, Inc. $35,649,486 Holding Largest Purchases this Quarter Q32 Bio, Inc. 2,092,106 shares (about $35.65M) Largest Sales this Quarter Dyne Therapeutics, Inc. 1,865,313 shares (about $52.96M)Day One Biopharmaceuticals 1,178,137 shares (about $19.46M)Kymera Therapeutics 480,900 shares (about $19.33M)Disc Medicine 267,939 shares (about $16.68M)Xilio Therapeutics 1,766,432 shares (about $1.91M) Sector Allocation Over TimeMap of 500 Largest Holdings ofAtlas Venture Life Science Advisors, LLC Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorDyne Therapeutics, Inc.$227,691,661$52,956,236 ▼-18.9%8,020,13621.0%Common StockKYMRKymera Therapeutics$216,169,952$19,332,180 ▼-8.2%5,377,36219.9%MedicalIRONDisc Medicine$142,403,127$16,681,882 ▼-10.5%2,287,23313.1%MedicalDAWNDay One Biopharmaceuticals$106,227,846$19,462,823 ▼-15.5%6,430,2579.8%MedicalTHRDTF Financial$102,970,1890.0%10,907,8599.5%MedicalKorro Bio, Inc.$100,736,2800.0%1,119,2929.3%Common StockAVTEAerovate Therapeutics$60,300,5930.0%2,039,2495.6%MedicalQ32 Bio, Inc.$35,649,486$35,649,486 ▲New Holding2,092,1063.3%Common StockGBIOGeneration Bio$33,697,5000.0%8,279,4843.1%MedicalVIGLVigil Neuroscience$19,903,7400.0%5,836,8741.8%MedicalREPLReplimune Group$17,143,1110.0%2,098,3001.6%MedicalIKNAIkena Oncology$7,125,8130.0%5,018,1780.7%MedicalAVROAVROBIO$5,812,9680.0%4,541,3810.5%MedicalDianthus Therapeutics, Inc.$5,609,370$1,500,000 ▼-21.1%186,9790.5%Common StockXLOXilio Therapeutics$1,072,345$1,907,747 ▼-64.0%992,9120.1%MedicalSPROSpero Therapeutics$1,045,094$698,019 ▼-40.0%607,6130.1%MedicalAKROAkero Therapeutics$0$8,388,511 ▼-100.0%00.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data: SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
